EMA has published an overview of its key recommendations of 2024 regarding the authorisation and safety monitoring of veterinary medicines. In 2024, EMA recommended...
OverviewThis is a summary of the European public assessment report (EPAR) for Opatanol. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
OverviewRekambys is used together with another medicine called cabotegravir to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that...
OverviewVocabria is used together with another medicine called rilpivirine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that...
OverviewThis is a summary of the European public assessment report (EPAR) for Inlyta. It explains how the Committee for Medicinal Products for Human...
OverviewRemsima is an anti-inflammatory medicine that contains the active substance infliximab. It is usually used when other medicines or treatments have failed, in...
OverviewSunosi is a medicine used to improve wakefulness and reduce excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnoea.Narcolepsy is a...
OverviewPosaconazole AHCL is an antifungal medicine used to treat adults with the following fungal diseases, when treatments with other antifungal medicines (amphotericin B,...
OverviewThis is a summary of the European public assessment report (EPAR) for Levitra. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for Potactasol. It explains how the Committee for Medicinal Products for Human...